Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease

B cell anergy plays a critical role in maintaining self-tolerance by inhibiting autoreactive B cell activation to prevent autoimmune diseases. Here, we demonstrated that Fc receptor-like 5 (Fcrl5) upregulation contributes to autoimmune disease pathogenesis by disrupting B cell anergy. Fcrl5—a gene w...

Full description

Bibliographic Details
Main Authors: Chisato Ono, Shinya Tanaka, Keiko Myouzen, Takeshi Iwasaki, Mahoko Ueda, Yoshinao Oda, Kazuhiko Yamamoto, Yuta Kochi, Yoshihiro Baba
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1276014/full
_version_ 1827387543553835008
author Chisato Ono
Shinya Tanaka
Keiko Myouzen
Takeshi Iwasaki
Mahoko Ueda
Yoshinao Oda
Kazuhiko Yamamoto
Yuta Kochi
Yoshihiro Baba
author_facet Chisato Ono
Shinya Tanaka
Keiko Myouzen
Takeshi Iwasaki
Mahoko Ueda
Yoshinao Oda
Kazuhiko Yamamoto
Yuta Kochi
Yoshihiro Baba
author_sort Chisato Ono
collection DOAJ
description B cell anergy plays a critical role in maintaining self-tolerance by inhibiting autoreactive B cell activation to prevent autoimmune diseases. Here, we demonstrated that Fc receptor-like 5 (Fcrl5) upregulation contributes to autoimmune disease pathogenesis by disrupting B cell anergy. Fcrl5—a gene whose homologs are associated with human autoimmune diseases—is highly expressed in age/autoimmunity-associated B cells (ABCs), an autoreactive B cell subset. By generating B cell-specific Fcrl5 transgenic mice, we demonstrated that Fcrl5 overexpression in B cells caused systemic autoimmunity with age. Additionally, Fcrl5 upregulation in B cells exacerbated the systemic lupus erythematosus-like disease model. Furthermore, an increase in Fcrl5 expression broke B cell anergy and facilitated toll-like receptor signaling. Thus, Fcrl5 is a potential regulator of B cell-mediated autoimmunity by regulating B cell anergy. This study provides important insights into the role of Fcrl5 in breaking B cell anergy and its effect on the pathogenesis of autoimmune diseases.
first_indexed 2024-03-08T16:03:45Z
format Article
id doaj.art-a234cc3fadbb43ac865e2196a80d4551
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-08T16:03:45Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-a234cc3fadbb43ac865e2196a80d45512024-01-08T09:44:03ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-09-011410.3389/fimmu.2023.12760141276014Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune diseaseChisato Ono0Shinya Tanaka1Keiko Myouzen2Takeshi Iwasaki3Mahoko Ueda4Yoshinao Oda5Kazuhiko Yamamoto6Yuta Kochi7Yoshihiro Baba8Division of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, JapanDivision of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, JapanLaboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, JapanDepartment of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanDepartment of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, JapanDepartment of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanLaboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, JapanDepartment of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, JapanDivision of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, JapanB cell anergy plays a critical role in maintaining self-tolerance by inhibiting autoreactive B cell activation to prevent autoimmune diseases. Here, we demonstrated that Fc receptor-like 5 (Fcrl5) upregulation contributes to autoimmune disease pathogenesis by disrupting B cell anergy. Fcrl5—a gene whose homologs are associated with human autoimmune diseases—is highly expressed in age/autoimmunity-associated B cells (ABCs), an autoreactive B cell subset. By generating B cell-specific Fcrl5 transgenic mice, we demonstrated that Fcrl5 overexpression in B cells caused systemic autoimmunity with age. Additionally, Fcrl5 upregulation in B cells exacerbated the systemic lupus erythematosus-like disease model. Furthermore, an increase in Fcrl5 expression broke B cell anergy and facilitated toll-like receptor signaling. Thus, Fcrl5 is a potential regulator of B cell-mediated autoimmunity by regulating B cell anergy. This study provides important insights into the role of Fcrl5 in breaking B cell anergy and its effect on the pathogenesis of autoimmune diseases.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1276014/fullFc receptor-like 5 (Fcrl5)B cellsage/autoimmunity-associated B cellsautoimmunityimmune toleranceanergy
spellingShingle Chisato Ono
Shinya Tanaka
Keiko Myouzen
Takeshi Iwasaki
Mahoko Ueda
Yoshinao Oda
Kazuhiko Yamamoto
Yuta Kochi
Yoshihiro Baba
Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease
Frontiers in Immunology
Fc receptor-like 5 (Fcrl5)
B cells
age/autoimmunity-associated B cells
autoimmunity
immune tolerance
anergy
title Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease
title_full Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease
title_fullStr Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease
title_full_unstemmed Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease
title_short Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease
title_sort upregulated fcrl5 disrupts b cell anergy and causes autoimmune disease
topic Fc receptor-like 5 (Fcrl5)
B cells
age/autoimmunity-associated B cells
autoimmunity
immune tolerance
anergy
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1276014/full
work_keys_str_mv AT chisatoono upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease
AT shinyatanaka upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease
AT keikomyouzen upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease
AT takeshiiwasaki upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease
AT mahokoueda upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease
AT yoshinaooda upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease
AT kazuhikoyamamoto upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease
AT yutakochi upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease
AT yoshihirobaba upregulatedfcrl5disruptsbcellanergyandcausesautoimmunedisease